• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Venlafaxine XR Teva
    / Teva

    Active Ingredient
    Venlafaxine (HCl) 75, 150 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft


    30 X 75 mg

    partial basket chart 18156 22297


    30 x 150 mg

    partial basket chart 18157 22309

    Related information


    Initial: 75 mg dly in single dose; for non-responders: Incr. up to 225 mg dly in dly increments of up to 75 mg at intervals of not less than 4 days. Re-ass. regular. to evaluat. benefit of long term ther. Hepat. impair: Reduce init. dose by 50%. Ren. impair: Reduce total dly dose by 25-50%. Pts. on hemodialys: Reduce by 50%, withhold until dialys. tmt complet. (4 hrs). Elderly: No dos. adjust. needed. Care when incr. dose. Maint./ extend. tmt: Perform period. evaluat. Discont: Taper grad., monitor pt. Switch. to/from MAOI: Allow at least 14 days between discont. MAOI and initiat. of ther. Allow at least 7 days of discont. ther. bef. start tmt. with MAOI.


    Treatment of depression. Maintenance of recurrent depression. Generalized anxiety disorder (GAD) – short term and long term. Social anxiety disorder (SAD).


    Known hypersensitivity to venlafaxine, or to any other ingredients of the preparation. Concomitant use in patients using MAOIs.

    Special Precautions

    Contact distributing company for full details.

    Side Effects

    Contact distributing company for full details.

    Drug interactions

    Contact distributing company for full details.